Revisiting India’s ultrasound laws

Revisiting India's Ultrasound Laws — UPSC Study Note

1. At a Glance

• Pre-Conception and Pre-Natal Diagnostic Techniques (PC&PNDT) Act, 1994 is India's primary legislation regulating the use of all ultrasound technology — enacted to curb sex-selective abortions and the decline of the child sex ratio. [S1]
• The Act mandates registration of every ultrasound machine and practitioner in India, including those used for non-obstetric purposes (cardiology, oncology, point-of-care). [S4]
• This broad regulatory sweep is now creating an unintended bottleneck for portable/handheld ultrasound devices that could enable community-based cancer screening in rural India. [S5]
• UPSC relevance: intersects GS-II (health policy, legislation, women's rights) and GS-I (gender issues, social justice); live debate on reforming colonial-era-style over-regulation vs. preventing misuse.

2. Why in the News

• June 2026: An article by Parth Sharma and Senthil Kumar A.R. in The Hindu (Print, June 26, 2026, Page 10, International Edition) argued that India's PCPNDT Act must be revisited to accommodate portable, handheld ultrasound devices for community-based breast and cervical cancer screening. [S5]
• A clinical vignette from rural Assam illustrated the cost of restricted access: a 45-year-old woman (Mrs. Janki) with a painless breast lump died of advanced-stage breast cancer after repeated delays caused partly by lack of nearby diagnostic infrastructure. [S5]
• The article specifically calls for an amendment to the PCPNDT Act to legalise community-based ultrasound using a high-frequency linear probe, which cannot be used for sex determination. [S5]

3. Background & Evolution

• 1994: The Pre-natal Diagnostic Techniques (Regulation and Prevention of Misuse) Act, 1994 (PNDT Act) enacted on 20 September 1994; came into force 1996. Objective: prevent sex-selective abortions fuelled by misuse of diagnostic technology. [S1]
• 2000: A Public Interest Litigation (PIL) filed challenging lax implementation of the PNDT Act. [S1]
• 2001: Census 2001 revealed a sharp decline in the child sex ratio (0–6 years), triggering legislative urgency. [S1]
• 2003 (14 February): PNDT Act amended and renamed PC&PNDT Act (Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994). Key additions: [S1][S2]
• Pre-conception sex selection brought within ambit.
• Ultrasound machines explicitly covered.
• Central Supervisory Board (CSB) empowered further.
• State Supervisory Boards and multi-member State Appropriate Authorities constituted.
• Punishments made more stringent.
• Post-2003 Rules: Government notified rules on six-months training in ultrasound, simplified Form F (record-keeping), code of conduct for Appropriate Authorities, exemption of registration fees for government diagnostic facilities. [S2]
• 2020 onward: Rapid proliferation of portable/handheld ultrasound globally raises question of whether a sex-determination-focused law should blanket all ultrasound use cases. [S4][S5]

4. Core Static Facts

[S1][S2][S5]

5. Multi-Dimensional Analysis

Social / Gender

• The PC&PNDT Act was a direct response to female foeticide — a gendered violence rooted in patriarchal son-preference. [S1]
• Paradoxically, over-regulation now denies rural women access to breast/cervical cancer screening — itself a gendered health burden. [S5]
• Women in remote areas (e.g., Assam) face a dual deprivation: absence of female foeticide protection and absence of cancer diagnostics. [S5]

Legal / Constitutional

• The Act's Section 3A prohibits sex selection; Section 4 restricts prenatal diagnostic techniques to registered institutions and qualified practitioners. [S1]
• The MoHFW clarified in 2020 that the PC&PNDT Act has NOT been suspended; all registrations remain mandatory. [S3]
• The current debate centres on whether delegated legislation (Rules) can carve out exceptions for non-foetal ultrasound probes, or whether a Parliamentary amendment is necessary. [S5]
• Relevant Constitutional angle: Article 21 (right to life/health) vs. state's duty under Article 39(a) (equal access to resources) — tension between protective regulation and access to healthcare.

Administrative / Governance

• All ultrasound machines — even those in cardiology, oncology, or point-of-care settings — must be registered under the Act, creating a compliance burden that deters rural deployment. [S4]
• Appropriate Authorities at district level are responsible for enforcement; capacity gaps lead to both under-enforcement (illegal sex determination persists) and over-enforcement (legitimate uses impeded). [S2]
• Proposed solution: risk-stratified regulation — exempt high-frequency linear probes used exclusively for surface imaging from sex-determination-related compliance requirements. [S5]

Scientific / Technological

• Portable, handheld ultrasound devices have drastically reduced cost and size, making community deployment feasible. [S5]
• A high-frequency linear probe images superficial structures (breast tissue, thyroid, lymph nodes) — technically incapable of foetal sex determination. [S5]
• This creates a rational basis for probe-type-based regulatory differentiation within the Act.

Ethical / Governance

• Regulatory design must balance two legitimate state interests: preventing sex selection (protecting girl children) and enabling cancer screening (protecting women's lives). [S5]
• Blanket prohibition on unregistered ultrasound was rational in 1994–2003 when technology was largely stationary and clinic-based; technological disruption requires regulatory adaptation. [S5]

6. Recent Developments (Last 12–18 Months)

• June 26, 2026: The Hindu publishes op-ed by Parth Sharma and Senthil Kumar A.R. calling for amendment to PCPNDT Act to legalise community-based cancer screening using high-frequency linear probes. [S5]
• Ongoing (2025–26): Expansion of National Cancer Screening Programme by MoHFW for breast, cervical, and oral cancers — creates policy pressure to resolve the ultrasound access bottleneck. [S5]
• Ongoing: Proliferation of portable ultrasound devices globally; India-specific evidence of under-utilisation due to PCPNDT compliance costs. [S4]

7. Prelims Hooks

1. The PNDT Act was enacted on 20 September 1994 and came into force in 1996. [S1]
2. The Act was amended and renamed PC&PNDT Act with effect from 14 February 2003. [S1]
3. The 2003 amendment was triggered by a PIL filed in 2000 and Census 2001 data showing decline in child sex ratio. [S1]
4. The implementing ministry is the Ministry of Health and Family Welfare (MoHFW). [S1]
5. Form F is the mandatory record-keeping form for every ultrasound conducted under the PC&PNDT Act. [S2]
6. The Central Supervisory Board (CSB) is the apex monitoring body under the Act. [S1]
7. The Act covers all ultrasound machines in India — including those used for non-obstetric purposes such as cardiology and oncology. [S4]
8. A high-frequency linear probe images superficial structures and is technically incapable of foetal sex determination. [S5]
9. The MoHFW issued a clarification in 2020 confirming that the PC&PNDT Act has not been suspended. [S3]
10. First-offence punishment under the Act: up to 3 years imprisonment and fine up to ₹10,000. [S1]
11. Post-2003, State-level Supervisory Boards and multi-member State Appropriate Authorities were mandated. [S1]
12. The Act prohibits sex selection both before and after conception (pre-conception sex selection was added only in 2003). [S1]
13. Exemption of registration fees for government diagnostic facilities was introduced via rules post-2003. [S2]

8. Mains Relevance

Plausible Mains Questions: 1. "The PC&PNDT Act, while essential for combating female foeticide, has inadvertently restricted access to community-based cancer diagnostics in rural India. Critically examine the regulatory design and suggest reforms." (GS-II, 15 marks) 2. "Technological disruption demands regulatory agility. With reference to the PC&PNDT Act and portable ultrasound technology, discuss how India should approach risk-proportionate health regulation." (GS-II / GS-III crossover) 3. "India's declining child sex ratio reflects deeper social pathologies that law alone cannot fix. Discuss the role of the PC&PNDT Act in addressing female foeticide and its limitations." (GS-I, 10 marks)

9. Related Topics to Study Next

10. Common Errors / Trap Areas

1. Wrong year: Aspirants confuse the PNDT Act (1994) with the PC&PNDT Act (2003). The 1994 Act was renamed/amended in 2003 — the original year 1994 is retained in the title.
2. Wrong ministry: The Act is under MoHFW, not the Ministry of Women & Child Development (which handles related schemes like BBBP).
3. Scope confusion: The Act covers all ultrasound machines in India — not just those used in prenatal diagnostics. Many candidates assume it applies only to obstetric scans.
4. Pre-conception addition: Pre-conception sex selection was not in the original 1994 Act; it was added by the 2003 amendment. A question asking "what did the 2003 amendment add?" targets this.
5. Suspended vs. active: A common misinformation (especially during COVID-era relaxations) was that the Act was suspended. MoHFW explicitly clarified in 2020 it was not suspended. [S3]

11. Sources

• [S1] Pre-Conception & Pre-Natal Diagnostics Techniques Act — PIB Press Release — https://www.pib.gov.in/newsite/erelcontent.aspx?relid=71711&reg=3&lang=2 — (Tier 1)
• [S2] Amending of PNDT Act — PIB Press Release — https://www.pib.gov.in/newsite/PrintRelease.aspx?relid=154520 — (Tier 1)
• [S3] MoHFW has not suspended the PC&PNDT Act — PIB Press Release — https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=1612635 — (Tier 1)
• [S4] PC-PNDT Part I (unintended consequences on non-obstetric ultrasound) — PubMed Central (NCBI) — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766905/ — (Tier 3 — reference/peer-reviewed)
• [S5] Revisiting India's ultrasound laws — Parth Sharma & Senthil Kumar A.R., The Hindu, 26 June 2026 — https://www.thehindu.com/todays-paper/2026-06-26/th_international/articleGPHG5QRP4-15101600.ece — (Tier 4 — Indian journalism / primary article)